26
Thu, Dec
48 New Articles

Dentons Advises HB Reavis on Sale of Symbiosy to HqO

Dentons Advises HB Reavis on Sale of Symbiosy to HqO

Slovakia
Tools
Typography
  • Smaller Small Medium Big Bigger
  • Default Helvetica Segoe Georgia Times

Dentons has advised HB Reavis on the sale of its in-house-developed technology platform Symbiosy to HqO.

HB Reavis is an international workspace provider.

HqO offers a real estate experience platform that assesses the health and performance of a customer's experience within a physical space while providing the necessary tools for operators to manage and optimize it.

According to Dentons, “following the transaction, HqO will power HB Reavis’ portfolio of workspaces and support its growing global customer base through a strategic partnership. Symbiosy offers a portfolio of smart building solutions consisting of system integrations, IoT, and software interfaces. Symbiosy’s portfolio of cutting-edge smart office technology solutions provides employee experience, data management, and visualization tools that support an enhanced workplace experience for improved performance.”

The Dentons team included Brastislava-based Partner Juraj Gyarfas and Senior Associate Radoslav Palka, Budapest-based Partner Rob Irving, and New York-based Partner Ilan Katz and Associate Michael Liou.

Dentons could not provide additional information on the matter.